glp 1 2025 GLP-1 Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Users: Trends on Long-Term

Description

Lim, R., Beekley, A., Johnson, D

Pick one reliable option and keep it low-pressure

[DOI] [PubMed] [Google Scholar] [7].Maiese K Cognitive Impairment in Multiple Sclerosis

S., et al., Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes: Potential Importance of Selectivity Over Dipeptidyl Peptidases 8 and 9, Diabetes 54, no

During GLP-1 treatment , maintain regular contact with your healthcare team and report: Any new or worsening anxiety symptoms , including excessive worry, panic attacks, or physical anxiety symptoms Changes in mood , sleep patterns, or appetite beyond expected treatment effects Difficulty coping with side effects such as nausea, which may exacerbate anxiety Concerns about body image or eating behaviours as weight changes occur NICE guidance recommends holistic care for people with diabetes and obesity, recognising the importance of psychological wellbeing